JPH11513686A - 線維素原受容体拮抗薬 - Google Patents
線維素原受容体拮抗薬Info
- Publication number
- JPH11513686A JPH11513686A JP9515931A JP51593197A JPH11513686A JP H11513686 A JPH11513686 A JP H11513686A JP 9515931 A JP9515931 A JP 9515931A JP 51593197 A JP51593197 A JP 51593197A JP H11513686 A JPH11513686 A JP H11513686A
- Authority
- JP
- Japan
- Prior art keywords
- ethyl
- alkyl
- acetyl
- piperidone
- pyridin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US560295P | 1995-10-19 | 1995-10-19 | |
GB9603371.7 | 1996-02-16 | ||
GB60/005,602 | 1996-02-16 | ||
GBGB9603371.7A GB9603371D0 (en) | 1996-02-16 | 1996-02-16 | Fibrinogen receptor antagonists |
PCT/US1996/016491 WO1997014417A1 (en) | 1995-10-19 | 1996-10-15 | Fibrinogen receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11513686A true JPH11513686A (ja) | 1999-11-24 |
Family
ID=26308744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9515931A Pending JPH11513686A (ja) | 1995-10-19 | 1996-10-15 | 線維素原受容体拮抗薬 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0866705A4 (de) |
JP (1) | JPH11513686A (de) |
AU (1) | AU713247B2 (de) |
CA (1) | CA2234967A1 (de) |
WO (1) | WO1997014417A1 (de) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002507600A (ja) * | 1998-03-23 | 2002-03-12 | アベンティス・ファーマスーティカルズ・プロダクツ・インコーポレイテツド | ピペリジジニルおよびn−アミジノピペリジニル誘導体 |
WO2007058305A1 (ja) * | 2005-11-18 | 2007-05-24 | Eisai R & D Management Co., Ltd. | シンナミド誘導体の製造方法 |
JP4495896B2 (ja) * | 2000-04-05 | 2010-07-07 | 第一三共株式会社 | エチレンジアミン誘導体 |
US7880009B2 (en) | 2004-05-26 | 2011-02-01 | Eisai R&D Management Co., Ltd. | Cinnamide compound |
US7897632B2 (en) | 2006-03-09 | 2011-03-01 | Eisai R&D Management Co., Ltd. | Multi-cyclic cinnamide derivatives |
US7923563B2 (en) | 2004-10-26 | 2011-04-12 | Eisai R&D Management Co., Ltd. | Amorphous object of cinnamide compound |
US7935815B2 (en) | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
US8008293B2 (en) | 2007-02-28 | 2011-08-30 | Eisai R&D Management Co., Ltd. | Bicyclic oxomorpholine derivative |
US9453000B2 (en) | 2007-08-31 | 2016-09-27 | Eisai R&D Management Co., Ltd. | Polycyclic compound |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5889023A (en) * | 1996-05-10 | 1999-03-30 | Merck & Co., Inc. | Fibrinogen receptor antagonist |
US6194435B1 (en) | 1996-10-11 | 2001-02-27 | Cor Therapeutics, Inc. | Lactams as selective factor Xa inhibitors |
US6369080B2 (en) | 1996-10-11 | 2002-04-09 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
US6262047B1 (en) | 1996-10-11 | 2001-07-17 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
US6063794A (en) | 1996-10-11 | 2000-05-16 | Cor Therapeutics Inc. | Selective factor Xa inhibitors |
JP2001521524A (ja) * | 1997-04-14 | 2001-11-06 | シーオーアール セラピューティクス インコーポレイテッド | 選択的Xa因子阻害剤 |
WO1998046627A1 (en) | 1997-04-14 | 1998-10-22 | Cor Therapeutics, Inc. | SELECTIVE FACTOR Xa INHIBITORS |
JP2001523226A (ja) | 1997-04-14 | 2001-11-20 | シーオーアール セラピューティクス インコーポレイテッド | 選択的Xa因子阻害剤 |
EP0975625A1 (de) | 1997-04-14 | 2000-02-02 | Cor Therapeutics, Inc. | AUSWÄHLEND Xa KAKTOR INHIBITOREN |
US6333321B1 (en) | 1997-08-11 | 2001-12-25 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
US6228854B1 (en) | 1997-08-11 | 2001-05-08 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
US6218382B1 (en) | 1997-08-11 | 2001-04-17 | Cor Therapeutics, Inc | Selective factor Xa inhibitors |
US6344450B1 (en) | 1999-02-09 | 2002-02-05 | Bristol-Myers Squibb Company | Lactam compounds and their use as inhibitors of serine proteases and method |
EP1156803A4 (de) | 1999-02-09 | 2004-03-17 | Bristol Myers Squibb Co | LACTAM INHIBITOREN DES FXa UND METHODE |
US6645968B2 (en) | 1999-08-03 | 2003-11-11 | Abbott Laboratories | Potassium channel openers |
US7225170B1 (en) | 2000-07-27 | 2007-05-29 | Pitney Bowes Inc. | Postage metering system for use with business reply mail |
US6511973B2 (en) | 2000-08-02 | 2003-01-28 | Bristol-Myers Squibb Co. | Lactam inhibitors of FXa and method |
HUP0304058A2 (hu) | 2001-01-30 | 2004-04-28 | Bristol-Myers Squibb Company | Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények |
JP2009525269A (ja) * | 2006-01-30 | 2009-07-09 | ユーロ−セルティーク エス.エイ. | カルシウムチャネルブロッカーとしての環状尿素化合物 |
US8207155B2 (en) | 2009-03-31 | 2012-06-26 | Vanderbilt University | Sulfonyl-azetidin-3-yl-methylamine amide analogs as GlyTl inhibitors, methods for making same, and use of same in treating psychiatric disorders |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5037808A (en) * | 1988-07-20 | 1991-08-06 | Monsanto Co. | Indolyl platelet-aggregation inhibitors |
US5039805A (en) * | 1988-12-08 | 1991-08-13 | Hoffmann-La Roche Inc. | Novel benzoic and phenylacetic acid derivatives |
US5051405A (en) * | 1989-10-10 | 1991-09-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Anti-thrombotic peptides and pseudopeptides |
NZ239876A (en) * | 1990-09-27 | 1993-12-23 | Merck & Co Inc | Glycyl-b-alanine derivatives and pharmaceutical compositions thereof. |
IL99537A (en) * | 1990-09-27 | 1995-11-27 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical preparations containing them |
HUT68769A (en) * | 1991-05-07 | 1995-07-28 | Merck & Co Inc | FIBRINOGéN RECEPTOR ANTAGONIST COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AS EFFECTIVE SUBSTANCE |
US5321034A (en) * | 1991-05-07 | 1994-06-14 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5272158A (en) * | 1991-10-29 | 1993-12-21 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5416099A (en) * | 1991-10-29 | 1995-05-16 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
CA2144762A1 (en) * | 1992-10-14 | 1994-04-28 | George D. Hartman | Fibrinogen receptor antagonists |
US5648368A (en) * | 1992-12-01 | 1997-07-15 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
WO1995025101A1 (en) * | 1994-03-14 | 1995-09-21 | Merck & Co., Inc. | Pyridil ethylation of lactams |
WO1995025088A1 (en) * | 1994-03-14 | 1995-09-21 | Merck & Co., Inc. | Pyridyl ethylation of lactam derivatives |
WO1996019221A1 (en) * | 1994-12-22 | 1996-06-27 | Smithkline Beecham Corporation | Fibrinogen receptor antagonists |
-
1996
- 1996-10-15 WO PCT/US1996/016491 patent/WO1997014417A1/en not_active Application Discontinuation
- 1996-10-15 CA CA002234967A patent/CA2234967A1/en not_active Abandoned
- 1996-10-15 AU AU74322/96A patent/AU713247B2/en not_active Ceased
- 1996-10-15 JP JP9515931A patent/JPH11513686A/ja active Pending
- 1996-10-15 EP EP96936505A patent/EP0866705A4/de not_active Withdrawn
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002507600A (ja) * | 1998-03-23 | 2002-03-12 | アベンティス・ファーマスーティカルズ・プロダクツ・インコーポレイテツド | ピペリジジニルおよびn−アミジノピペリジニル誘導体 |
JP4495896B2 (ja) * | 2000-04-05 | 2010-07-07 | 第一三共株式会社 | エチレンジアミン誘導体 |
US7880009B2 (en) | 2004-05-26 | 2011-02-01 | Eisai R&D Management Co., Ltd. | Cinnamide compound |
US7923563B2 (en) | 2004-10-26 | 2011-04-12 | Eisai R&D Management Co., Ltd. | Amorphous object of cinnamide compound |
WO2007058305A1 (ja) * | 2005-11-18 | 2007-05-24 | Eisai R & D Management Co., Ltd. | シンナミド誘導体の製造方法 |
US7897632B2 (en) | 2006-03-09 | 2011-03-01 | Eisai R&D Management Co., Ltd. | Multi-cyclic cinnamide derivatives |
US7973033B2 (en) | 2006-03-09 | 2011-07-05 | Eisai R&D Management Co., Ltd. | Multi-cyclic cinnamide derivatives |
US8008293B2 (en) | 2007-02-28 | 2011-08-30 | Eisai R&D Management Co., Ltd. | Bicyclic oxomorpholine derivative |
US7935815B2 (en) | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
US9453000B2 (en) | 2007-08-31 | 2016-09-27 | Eisai R&D Management Co., Ltd. | Polycyclic compound |
Also Published As
Publication number | Publication date |
---|---|
AU713247B2 (en) | 1999-11-25 |
EP0866705A4 (de) | 1999-03-03 |
WO1997014417A1 (en) | 1997-04-24 |
EP0866705A1 (de) | 1998-09-30 |
AU7432296A (en) | 1997-05-07 |
CA2234967A1 (en) | 1997-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH11513686A (ja) | 線維素原受容体拮抗薬 | |
AU712082B2 (en) | Fibrinogen receptor antagonists | |
US5854245A (en) | Fibrinogen receptor antagonists | |
AU719102B2 (en) | Fibrinogen receptor antagonist prodrugs | |
CN100369917C (zh) | 作为凝血酶受体拮抗剂的喜巴辛类似物 | |
CA2258093A1 (en) | Fibrinogen receptor antagonists | |
JP2001518932A (ja) | トロンビン阻害薬 | |
AU713676B2 (en) | Integrin receptor antagonists | |
JPH08504194A (ja) | フィブリノーゲンレセプターアンタゴニスト | |
JP2001500864A (ja) | トロンビン阻害物質 | |
US5780480A (en) | Fibrinogen receptor antagonists | |
US5932582A (en) | Fibrinogen receptor antagonist prodrugs | |
US5852045A (en) | Fibrinogen receptor antagonists | |
CA2257937A1 (en) | Fibrinogen receptor antagonist prodrugs | |
US5952306A (en) | Integrin receptor antagonists | |
JP2002527424A (ja) | β−アラニン誘導体の新規製造法 | |
US5494921A (en) | Fibrinogen receptor antagonists | |
US5525617A (en) | Fibrinogen receptor antagonists | |
US5990107A (en) | Fibrinogen receptor antagonist prodrugs | |
US5889023A (en) | Fibrinogen receptor antagonist | |
AU702025B2 (en) | Fibrinogen receptor antagonist | |
GB2312895A (en) | Fibrinogen receptor antagonists |